Funding finder

Funding opportunity sorting options

43 opportunities found using the current filters, sorted by publication date

Funding opportunity list

MRC infections and immunity partnership grants: Sep 2021

Funding is available from MRC’s Infections and Immunity Board to support new partnerships between researchers in the area of infections and immunity.

Funding varies widely for partnerships lasting between one and five years.

This funding opportunity runs three times every year.

MRC infections and immunity new investigator research grants: Sep 2021

Funding is available from MRC’s Infections and Immunity Board to support researchers ready to progress to independence through their first major grant as a principal investigator.

There is no limit to the funding that you can request. This funding opportunity runs three times every year.

MRC neurosciences and mental health partnership grants: Sep 2021

Funding is available from MRC’s Neurosciences and Mental Health Board to support new partnerships between researchers in the area of neurosciences and mental health.

Funding varies widely for partnerships lasting between one and five years. This funding opportunity runs three times every year.

MRC neurosciences and mental health new investigator research grants: Sep 2021

Funding is available from MRC’s Neurosciences and Mental Health Board to support researchers ready to progress to independence through their first major grant as a principal investigator.

There is no limit to the funding that you can request. This funding opportunity runs three times every year.

Developmental pathway funding scheme: Nov 2021

Researchers can apply for MRC funding to turn fundamental discoveries into benefits to human health.

This scheme supports translational research across all diseases and interventions, from pre-clinical development to early-stage clinical testing. It runs three times a year and there is no limit to the amount that can be requested.

Developmental pathway funding scheme: July 2021

Researchers can apply for MRC funding to turn fundamental discoveries into benefits to human health.

This scheme supports translational research across all diseases and interventions, from pre-clinical development to early-stage clinical testing. It runs three times a year and there is no limit to the amount that can be requested.

Investigating the mechanisms to prevent hypersensitivities to food

Apply for funding to reduce and prevent food hypersensitivities.

UK-based researchers must apply as part of a transnational consortium.

Projects should focus on one or more of the following:

  • mechanisms that induce or prevent food intolerance or allergies
  • improving detection of adverse reactions
  • the impact of food ingredients and processing.

MRC molecular and cellular medicine new investigator research grant: May 2021

Funding is available from MRC’s Molecular and Cellular Medicine Board to support researchers ready to progress to independence through their first major grant as a principal investigator.

There is no limit to the funding that you can request. This funding opportunity runs three times every year.

MRC molecular and cellular medicine research grant: May 2021

An MRC research grant is the main way for UK-based medical researchers to apply for researcher-led project funding. You should apply if your research is on molecular and cellular medicine.

There is no limit to the funding you can request. This funding opportunity runs three times every year.

Expressions of interest: National Mouse Genetics Network clusters

Register your interest to lead a National Mouse Genetics Network research cluster. Each cluster will integrate mouse and human or clinical genetics to address a disease, technology or concept-driven challenge.

You must be at a research organisation eligible for UKRI funding.

You can also register your interest to be an associate member, offering expertise to the clusters or network.

NOTEThis is the first phase of our new website – let us know if you have feedback or would like to help us test new developments.